Condition / Intervention Metastatic Breast Cancer
Title SystHERs Study
Study # ML28257
Purpose An observational cohort study of treatment patterns and outcomesin patients with HER2 positive metastatic breast cancer.
Investigator Neal A Fischbach MD
Contact Information For more information about this study and to inquire about eligibility, 203-384-3611
Contact Us Use this form to email us
More Information View this trial on

Inclusion Criteria:

  • Adult patients, >/=18 years of age
  • Initial diagnosis of HER2+ MBC, as diagnosed by the treating physician, no more than 6 months prior to study enrollment
  • Availability of cancer-specific historical data points in the patient's medical records